Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04100850
Other study ID # AE-Mental
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2019
Est. completion date December 31, 2023

Study information

Verified date May 2023
Source Universidade Federal do vale do São Francisco
Contact Rodrigo GS Carvalho, PhD
Phone +5587999832015
Email rodrigocarvalhofisio@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: To compare the effectiveness between aquatic exercises (water aerobics versus Watsu) versus control groups, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression.


Description:

Introduction: Considered as the "21st century disease", depression is a silent disease that stands out for its high prevalence and high morbidity, leading to serious consequences. With treatments made in aquatic environment, among them the Water aerobics and Watsu. Objective: To compare the effectiveness between aquatic exercises versus Watsu and versus control group, for improving the outcomes of depression, anxiety, stress, sleep quality, functionality, cognition and quality of life in patients with depression. Methods: This study will be a randomized clinical trial, which will last for two months with a follow-up of one month. All participants will be assessed using specific questionnaires for each outcome and an Improvement Perception Scale (MS). Seventy eight (78) patients with a medical diagnosis of depression, aged 18 to 60 years, who will be allocated to three groups (26 patients for each group) will be treated. GROUP 1: Aquatic exercises (aerobic and resistance), collective session, twice a week lasting 50 min; GROUP 2: Watsu (water shiatsu), individual session, twice a week lasting 50 min; Group 3: control, people with depression. Statistical analysis: Normality distribution will be by Shapiro-Wilk test. For comparisons of the means between and within the outcome groups will be used through Generalized Estimation Equations, with its own syntax, linear distribution and, when necessary, multiple comparisons will be performed using the Bonferroni test to identify differences. Will be calculated for comparisons between the final and initial moments and initial follow-up in each group, statistics such as: mean difference (95% CI), standard deviation of the difference, effect size (Cohen's d). The statistical significance adopted was 5% and the analyzes were performed using the statistical programs SPSS 22.0 and R 3.2.4. The intention-to-treat analysis will be performed.


Recruitment information / eligibility

Status Recruiting
Enrollment 78
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Age between 18 and 60 years old; - Sedentary and who have not had physical therapy and physical activity in the last three months; - Clinical and cognitive conditions for performing pool activities and moderate aerobic exercise; - Who have not undergone high complexity surgical procedures in the last six months; no neuro-musculosqueletal diseases; - No contraindications to exercise; such as: urinary and / or fecal incontinence and dermatological diseases; - Individuals with a medical diagnosis of depression. Exclusion Criteria: - If they have up to three absences during the intervention period; - If they have any adverse effects, such as: allergy or dermatitis; - Unable to continue study due to change of address or hospitalization.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aquatic Exercises
twice a week, lasting 50 minutes, for two months.
Watsu
twice a week, lasting 50 minutes, for two months.

Locations

Country Name City State
Brazil Physical Education College Petrolina Pernambuco

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do vale do São Francisco

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Improvement Perception Improvement Perception Scale (0-7) pos (8 week)
Primary Depression Beck Depression Inventory (better 0-63 worse points) change depression at 8 weeks and follow-up at 12 weeks
Primary Anxiety Beck Anxiety Inventory (better 0-63 worse points) change anxiety at 8 weeks and follow-up at 12 weeks
Secondary Stress Depression, Anxiety and Stress Scale (DASS-21) (better 0 - worse >34) change stress at 8 weeks and follow-up at 12 weeks
Secondary Quality of Life Questionnaire 12-Item Short-Form Health Survey (SF-12) (worse 0 - better 100) change quality of live at 8 weeks and follow-up at 12 weeks
Secondary Sleep Quality Pittsburgh Sleep Quality Index (PSQI) (better 0 - worse 21) change sleep quality at 8 weeks and follow-up at 12 weeks
Secondary Life Style Scale Fantastic Life Style Scale (worse 0 - better 100) change life style at 8 weeks and follow-up at 12 weeks
Secondary Cognitive Montreal Cognitive Assessment (MOCA) (worse 0 - better 30) change cognitive at 8 weeks and follow-up at 12 weeks
Secondary Functionally Six-minute Walk Test (6m-WT) change functionally at 8 weeks and follow-up at 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A